Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2026 Volume 31 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2026 Volume 31 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report

A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report

  • Authors:
    • Yujie Ji
    • Shelin Liu
    • Yunwei Wang
    • Youcai Zhao
    • Zheng Cai
    • Bing Li
  • View Affiliations / Copyright

    Affiliations: Department of Neurosurgery, Jiangnan University Medical Center, Jiangnan University, Wuxi, Jiangsu 214000, P.R. China, Department of Bioinformatics, School of Science, Xi'an Jiaotong‑Liverpool University, Suzhou, Jiangsu 215000, P.R. China, Department of Pathology, Nanjing No. 1 People's Hospital, Nanjing, Jiangsu 210000, P.R. China
  • Article Number: 119
    |
    Published online on: February 26, 2026
       https://doi.org/10.3892/etm.2026.13114
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Cerebral syphilitic gummata are rare granulomatous lesions associated with tertiary syphilis, typically developing several years after the initial infection. Early‑stage syphilis with cerebral gummata and accompanying severe neurological symptoms is rare. Failure to recognize the lesions or delays in diagnosis may lead to marked and potentially irreversible central nervous system injury. In the present study, the case of a 60‑year‑old man with a 6‑month history of syphilis who presented with progressive right‑sided limb weakness and dysarthria is reported. Brain magnetic resonance imaging revealed multiple ring‑enhancing lesions accompanied by extensive perilesional edema. Due to the severity of the symptoms and a notable mass effect, surgical intervention was performed to remove the gummatous lesion, followed by histopathological confirmation of syphilitic granuloma. The patient was subsequently treated with high‑dose intravenous penicillin, which led to notable improvement in neurological function and resolution of the symptoms; follow‑up imaging demonstrated no recurrence of intracranial lesions. In conclusion, the present case illustrates the importance of early recognition and a multidisciplinary approach in the management of neurosyphilis with cerebral gummata. Increased awareness of this rare presentation may facilitate a timely diagnosis and appropriate treatment in similar clinical scenarios.

Introduction

Syphilis is a sexually transmitted infection caused by the spirochete Treponema pallidum (1,2). Despite its long history, syphilis continues to pose a notable public health challenge due to its ability to mimic a wide array of clinical conditions. Neurosyphilis (NS), a severe complication resulting from the invasion of Treponema pallidum into the central nervous system, can occur at any stage of syphilis. Historically, up to ~30% of untreated patients with syphilis developed NS; however, with antibiotic treatment, symptomatic NS is now estimated to occur in 1.5-13% of syphilis cases, and cohort data indicate that, among individuals with human immunodeficiency virus (HIV) infection, the incidence of NS is twice that of those without HIV infection (3,4). Cerebral syphilitic gummata (CSG) are rare manifestations typically associated with tertiary syphilis (5). In Cushing's (6) frequently cited case series of 2,203 intracranial tumors published in 1932, only 12 cases (0.5%) were identified as CSG. In a review of intracranial tumors by Grant (7) in 1956, which included 2,326 patients, only 5 cases (0.2%) were diagnosed as CSG. Likewise, Katsura et al (8), in a review of all neurosurgical cases in Japan prior to 1959, identified only 12 cases of syphilitic gummas among 3,312 patients, yielding an incidence of 0.4%. Although large-scale retrospective studies from recent years are lacking, the limited number of sporadic case reports published over the past two decades suggests that CSG has become an even rarer disease entity. The gummata are granulomatous lesions that may develop in various organs, including the brain, as a consequence of a chronic inflammatory response to persistent infection (9). Within the central nervous system, these lesions can give rise to diverse neurological symptoms depending on lesion size and location, including headaches, seizures, focal neurological deficits, cognitive impairment and behavioral disturbances. Owing to their rarity and heterogeneous presentation, CSG are frequently misdiagnosed or mistaken for other conditions, such as neoplasms, abscesses or other infectious or inflammatory disorders (10). The present study reports a case of CSG in a 60-year-old male patient who rapidly developed hemiplegia of the right upper and lower limbs over several days. The present case underscores the importance of considering NS in patients presenting with atypical neurological symptoms, particularly those with risk factors for syphilis infection.

Case report

Patient information

A 60-year-old man with a 6-month history of syphilis was admitted to to Jiangnan University Medical Center (Wuxi, China) in December 2023 for progressive right-sided limb weakness and slurred speech over a 2-week period. On admission, the patient presented with complete right-sided hemiplegia. The patient's medical history was unremarkable, with no hypertension, diabetes or other chronic illnesses, and the patient was not taking any regular medications and denied any substance abuse. There was no family history of sexually transmitted infections or related conditions.

Because the lesion, which was detected during the present hospitalization on brain magnetic resonance imaging (MRI) as a left frontal parasagittal mass, exhibited a firm consistency during surgical resection, appearing grayish, poorly circumscribed and lacking a clear capsule, which differed from that of typical neoplastic lesions, a review of the patient's medical history was conducted after surgery and revealed that the patient had a single hard chancre, that was 0.5x0.5 cm in size, on the glans penis that appeared ~20 days after a sexual encounter 6 months prior to presentation at the hospital; however, the patient did not receive any treatment at the time. The clinical course is summarized in a timeline diagram (Fig. 1).

Timeline diagram of the clinical
course. MRI, magnetic resonance imaging.

Figure 1

Timeline diagram of the clinical course. MRI, magnetic resonance imaging.

Clinical presentation

During the initial examination, the patient demonstrated slurred speech with dysarthria. Neurological assessment revealed right-sided hemiparesis accompanied by mild hyperreflexia. Cranial nerve function was intact, and the remainder of the physical examination was unremarkable. The patient exhibited no signs of meningismus, and the vital signs were stable.

Diagnostic workup

Initial laboratory tests, including complete blood count, basic metabolic panel and liver function tests, were within normal limits. Infectious disease screening showed a signal-to-cutoff ratio value of 26.91 for Treponema pallidum antibodies; testing for HIV was negative at the time of admission. Given the neurological deficits of the patient, brain MRI was performed, which demonstrated a nodule in the left frontal lobe with extensive surrounding edema. On contrast-enhanced imaging, the lesion appeared as an abnormally enhancing mass measuring ~18x21x28 mm, involving the adjacent dura mater and the falx cerebri (Fig. 2).

Preoperative brain magnetic resonance
imaging scans. (A) Axial T1-weighted image demonstrating a
hypointense mass in the left frontal lobe. (B) Axial T2-weighted
image showing the left frontal lobe lesion with extensive
surrounding hyperintense edema. (C) Contrast-enhanced coronal
T1-weighted image revealing prominent ring enhancement of the
lesion. (D) Contrast-enhanced sagittal T1-weighted image
demonstrating the close relationship between the lesion and the
adjacent dura mater.

Figure 2

Preoperative brain magnetic resonance imaging scans. (A) Axial T1-weighted image demonstrating a hypointense mass in the left frontal lobe. (B) Axial T2-weighted image showing the left frontal lobe lesion with extensive surrounding hyperintense edema. (C) Contrast-enhanced coronal T1-weighted image revealing prominent ring enhancement of the lesion. (D) Contrast-enhanced sagittal T1-weighted image demonstrating the close relationship between the lesion and the adjacent dura mater.

Treatment

Based on the clinical symptoms and imaging findings, a preliminary diagnosis of a left frontal lobe space-occupying lesion was made, with the consideration of a malignant neoplastic lesion or metastatic tumor; however, a high-grade glioma could not be excluded. Consequently, the patient underwent a craniotomy for the resection of the intracranial mass. Intraoperatively, a gray-yellow lesion was observed near the midline of the left frontal lobe, which was markedly adherent to the meninges and falx cerebri; the lesion had a firm texture and lacked a distinct capsule, and swelling of the brain tissue was evident. Under the microscope, dissection was performed along the surrounding edema zone of the lesion until a complete resection was achieved. During the craniotomy, the intracranial pressure was elevated and marked brain bulging was observed; consequently, the local bone flap was removed. The bone flap was not replaced at wound closure, resulting in a left frontal decompressive craniectomy (Fig. 3). During follow-up, cerebral edema gradually resolved; however, no secondary cranioplasty was performed because the patient declined cranial reconstruction. Postoperatively, the patient was treated with routine measures such as dehydration therapy to reduce intracranial pressure.

Intraoperative images of the surgical
resection of the left frontal lobe lesion. (A) Intraoperative view
showing the exposed left frontal lobe lesion without a discernible
capsule. (B) Dissection plane along the margins of the lesion
during surgical separation. (C) Intraoperative image demonstrating
firm adherence of the lesion to the falx cerebri. (D)
Intraoperative view confirming complete removal of the lesion. (E)
Final operative field showing adequate hemostasis after tumor
resection. (F) Gross appearance of the lesion after surgical
resection.

Figure 3

Intraoperative images of the surgical resection of the left frontal lobe lesion. (A) Intraoperative view showing the exposed left frontal lobe lesion without a discernible capsule. (B) Dissection plane along the margins of the lesion during surgical separation. (C) Intraoperative image demonstrating firm adherence of the lesion to the falx cerebri. (D) Intraoperative view confirming complete removal of the lesion. (E) Final operative field showing adequate hemostasis after tumor resection. (F) Gross appearance of the lesion after surgical resection.

Intraoperatively, it was observed that the lesion was firmer than commonly encountered neoplastic lesions, and histopathological analysis confirmed the diagnosis of a gummatous lesion consistent with tertiary syphilis, showing granulomatous inflammation with central necrosis, surrounded by lymphocytes, plasma cells and macrophages. For histopathological examination, the resected tissue was fixed in 10% neutral buffered formalin at room temperature for 24 h, embedded in paraffin and sectioned at a thickness of 4 µm. Sections were stained with H&E using standard protocols at room temperature, with hematoxylin staining for 5 min followed by eosin staining for 2 min. Microscopic evaluation was performed using a light microscope at magnifications of x100 and x400. No evidence of malignancy or other infectious agents was found. Extensive plasma cell infiltration was observed around the small vessels in the brain tissue, leading to the formation of vasculitis.

For immunohistochemical analysis, the resected tissue was fixed in 10% neutral buffered formalin at room temperature for 24 h, paraffin-embedded and sectioned at a thickness of 4 µm. Sections were deparaffinized in xylene and rehydrated through a descending ethanol series (100, 95, 85 and 75%), followed by rinsing in PBS (41404ES76; Shanghai Yeasen Biotechnology Co., Ltd.). Antigen retrieval was performed by heating the sections in citrate buffer (pH 6.0) at 95-100˚C for 15 min. Endogenous peroxidase activity was quenched by incubation with 3% hydrogen peroxide. The sections were permeabilized with 0.1% Triton X-100 and blocked with 5% normal goat serum (36119ES10; Shanghai Yeasen Biotechnology Co., Ltd.) at room temperature for 30 min. Sections were incubated overnight at 4˚C with a commercially available imported primary antibody against Treponema pallidum (dilution, 1:200; ZA-0199; Beijing Zhongshan Jinqiao Biotechnology Co., Ltd.). After washing with PBS (41404ES76; Shanghai Yeasen Biotechnology Co., Ltd.), an HRP-conjugated goat anti-rabbit secondary antibody (dilution, 1:500; ab6721; Abcam) was applied at room temperature for 30 min. Chromogenic detection was performed using 3,3'-diaminobenzidine. Immunostained sections were examined and imaged using a light microscope at magnifications of x200 and x400. Immunohistochemical staining with anti-syphilis spirochetes antibodies revealed numerous brown spirochetes (Fig. 4A and B).

Postoperative pathological images. (A)
The lesion consists of dense inflammatory infiltration composed of
lymphocytes, plasma cells, granulocytes, histiocytes and
fibroblasts. The black arrow indicates features of vasculitis and
the yellow arrows show plasma cells surrounding the vasculitis
(scale bar, 100 µm). (B) Immunohistochemical staining with
anti-syphilis spirochetes antibodies revealed numerous elongated,
curved and spiral shaped brown Treponema pallidum on the
blood vessel walls; black arrows reveal numerous Treponema
pallidum (scale bar, 100 µm).

Figure 4

Postoperative pathological images. (A) The lesion consists of dense inflammatory infiltration composed of lymphocytes, plasma cells, granulocytes, histiocytes and fibroblasts. The black arrow indicates features of vasculitis and the yellow arrows show plasma cells surrounding the vasculitis (scale bar, 100 µm). (B) Immunohistochemical staining with anti-syphilis spirochetes antibodies revealed numerous elongated, curved and spiral shaped brown Treponema pallidum on the blood vessel walls; black arrows reveal numerous Treponema pallidum (scale bar, 100 µm).

Routine cerebrospinal fluid (CSF) testing and biochemical analysis were performed postoperatively. The CSF was clear in appearance, with a normal cell count and a protein concentration of 48.2 mg/dl (reference range, 15-45 mg/dl). Serum and CSF toluidine red unheated serum test (TRUST) and Treponema pallidum particle agglutination (TP-PA) tests were performed; the serum TRUST test showed a result of 1:64, whereas the result in the CSF was negative. The syphilis antibody by TP-PA results for both serum (18.84) and CSF (23.30) were markedly higher than the reference range (<1); these results are presented in Table I.

Table I

Syphilis test results.

Table I

Syphilis test results.

SampleTestResultReference range
SerumTRUST1:64Negative
SerumSyphilis Ab by TP-PA, S/CO18.84<1
SerumHIV statusNegativeNegative
CSFTRUSTNegativeNegative
CSFSyphilis Ab by TP-PA, S/CO23.30<1
CSFWBCs (x106/l)50-8
CSFProtein, mg/dl48.215-45

[i] CSF, cerebral spinal fluid; TRUST, toluidine red unheated serum test; WBC, white blood cell; S/CO, signal-to-cutoff ratio; TP/PA, Treponema pallidum particle agglutination; Ab, antibody; HIV, human immunodeficiency virus.

After a definitive pathological diagnosis, the patient was started on high-dose intravenous penicillin G (24 million units per day, administered as 6 million units every 6 h) for 14 days to address the remaining infection in the central nervous system. Corticosteroid therapy was also initiated to reduce postoperative cerebral edema and mitigate the risk of the Jarisch-Herxheimer reaction, a common inflammatory response to the treatment of syphilis. Dexamethasone was administered at a dose of 10 mg/day intravenously for 3 days, followed by gradual tapering over the subsequent 5 days.

Outcome and follow-up

The patient recovered well from surgery, with gradual improvement in neurological function. The headaches resolved and there was marked improvement in speech function and right-sided hemiparesis. On the seventh postoperative day, the patient's muscle strength of the right upper and lower limbs reached grade IV (grade II preoperatively), and speech was clear. The patient was discharged on oral amoxicillin (500 mg every 8 h) for an additional 2 weeks. Regular follow-up was arranged with neurology and infectious disease specialists at 1, 3 and 6 months after discharge, including neurological examinations, repeat serological testing for syphilis and follow-up brain MRI to assess lesion resolution. At the 3-month follow-up, the patient remained asymptomatic, with no recurrence of neurological symptoms. The 3-month follow-up MRI showed a marked reduction in the size of the cerebral lesions and surrounding edema, indicating a favorable prognosis (Fig. 5A-C).

Follow-up magnetic resonance imaging
scans 3 months postoperatively. (A) Axial T2-weighted image
demonstrating marked reduction of edema in the frontal lobe. (B)
Contrast-enhanced coronal T1-weighted image showing no residual
contrast-enhancing lesion in the surgical area. (C)
Contrast-enhanced sagittal T1-weighted image confirming the absence
of contrast-enhancing lesions at the operative site.

Figure 5

Follow-up magnetic resonance imaging scans 3 months postoperatively. (A) Axial T2-weighted image demonstrating marked reduction of edema in the frontal lobe. (B) Contrast-enhanced coronal T1-weighted image showing no residual contrast-enhancing lesion in the surgical area. (C) Contrast-enhanced sagittal T1-weighted image confirming the absence of contrast-enhancing lesions at the operative site.

Discussion

NS complications occur in 4-10% of untreated or inadequately treated patients with syphilis. The neurological manifestations in advanced NS are diverse (11); early NS often presents without neurological symptoms and primarily affects the meninges and blood vessels, whereas late NS can involve the meninges, blood vessels and brain parenchyma. This progression can lead to conditions such as meningitis, gummas or cerebral infarctions (12-14). CSG is a rare clinical manifestation of NS. In a review of 286 reported cases of NS, Drago et al (4) identified only 10 cases of CSG (3.5%). In a more recent cross-sectional study, the incidence of CSG was found to be 1.8% among 397 patients with NS (15); however, in both large studies, the cases of CSG occurred years or even decades after the initial infection. In the present study, the case is unusual in that the patient developed a gummatous lesion in the brain within just 6 months of being diagnosed with syphilis, representing an atypical and rare presentation of this condition in the early stage of the disease. To the best of our knowledge, this rapid progression is rarely documented in the literature and it underscores the variability in the clinical manifestations of syphilis (16,17).

The radiological appearance of syphilitic gummas frequently mimics other intracranial pathologies. Gliomas, especially high-grade variants, may present with irregular enhancement, marked perilesional edema and a mass effect similar to that observed in gummas. However, gliomas tend to show infiltrative margins and elevated perfusion metrics, whereas gummas more often demonstrate well-circumscribed granulomatous enhancement with a surrounding inflammatory halo.

Reports have suggested that penicillin treatment can reduce the size of CSG lesions, thereby avoiding the need for surgery (18,19). However, in the present case, the condition of the patient deteriorated rapidly, making it impractical to wait for the time required for penicillin therapy. Therefore, in the present case, the decision to pursue surgical intervention was based on the severity of the patient's symptoms and the need to alleviate the mass effect caused by the gummatous lesion. Surgical removal of the lesion not only provided symptomatic relief but also allowed for histopathological confirmation of the diagnosis, revealing granulomatous inflammation consistent with syphilitic gummata. Therefore, surgical biopsy plays a particularly notable role when imaging is inconclusive, allowing definitive histopathological confirmation and exclusion of neoplasia. Decompression may also provide symptomatic relief when rapid deterioration occurs. Nevertheless, once a diagnosis is established, medical therapy alone is often sufficient and unnecessary extensive resections should be avoided (20,21).

The present case is noteworthy as it illustrates that CSG can occur much earlier in the course of syphilis than is typically expected. It emphasizes the importance of considering NS and its atypical manifestations, even in patients with a relatively short history of syphilis. Clinicians should maintain a high degree of suspicion for NS in patients presenting with new-onset neurological symptoms, regardless of the duration since syphilis diagnosis, especially when accompanied by risk factors or inadequate treatment history.

The occurrence of CSG in early syphilis may reflect an aggressive host response or a particularly virulent strain of Treponema pallidum (22). To the best out our knowledge, the pathophysiology behind the formation of gummata in such a short time frame is not well understood. Typically, gummatous lesions result from a chronic granulomatous inflammatory response to persistent infection. In the present patient, elevated Treponema pallidum antibody titers (signal-to-cutoff ratio, 18.84) and cerebrospinal fluid abnormalities, including increased protein and the positive CSF TP-PA test, suggested that the immune response in the present patient might have been unusually robust or dysregulated; this could be due to genetic predisposition, immune status or other unknown factors (23). As part of the present study, a literature review of reported cases of early-onset syphilitic gummas was conducted, as summarized in Table II. Among the cases, a substantial proportion of patients had comorbid conditions associated with immunosuppression, including diabetes, HIV infection or concurrent systemic infections, which may have contributed to the early development of gummatous lesions. Most lesions involved the frontal or temporal lobes, frequently presented with focal neurological deficits such as hemiparesis or speech disturbances, and were generally treated with a combination of surgical resection and antibiotic therapy. Follow-up data indicated that most patients achieved favorable neurological recovery when treated promptly. This detailed overview underscores the importance of considering underlying immunosuppressive conditions and lesion location when evaluating early-onset intracranial syphilitic gummas.

Table II

Literature review on early-onset cerebral syphilitic gummata.

Table II

Literature review on early-onset cerebral syphilitic gummata.

First author, yearAge, yearsSexOnset time, monthsLesion locationPast historyTreatmentOutcome(Refs.)
Sasaki et al, 201947M9Left frontal and temporal lobesType 2 diabetesPenicillin GNo neurological deficits or residual lesions on MRI.(13)
Zhang et al, 201756M7Left parietal lobe-Operation and penicillin GEdema resolved, no lesion recurrence.(17)
Mu et al, 202465F12Multiple intracranial lesionsLiver abscessPenicillin GSymptoms resolved, lesion disappeared(20)
Tsuboi et al, 201621M5Left frontal lobeHIV(+)Penicillin GSymptoms improved, lesion shrunk(21)
Present case60M6Left frontal lobe-Operation and penicillin GSymptoms improved, no lesion recurrence-

[i] M; male; F, female; HIV, human immunodeficiency virus; MRI, magnetic resonance imaging.

As syphilis rates continue to rise each year, it becomes increasingly more important to consider CSG, a condition that is often overlooked and occurs less frequently (24). There is no definitive standard for diagnosing CSG; although craniocerebral tumors are more common than syphilis, it is crucial to differentiate patients exhibiting nervous system symptoms and positive serological test results for syphilis from those with CSG. Imaging plays a key role in diagnosing CSG; however, when faced with a rapidly deteriorating patient, surgical intervention is often the most effective approach. For patients experiencing severe cerebral edema, decompressive craniectomy can be a viable option.

In conclusion, the present case highlights an atypical and rare presentation of CSG occurring just 6 months after the initial diagnosis of syphilis, challenging the conventional understanding that such manifestations are predominantly associated with tertiary syphilis after numerous years of infection. Clinicians should consider NS in the differential diagnosis of unexplained neurological symptoms, regardless of the duration of syphilis, to facilitate a timely and effective intervention.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The data generated in the present study are included in the figures and/or tables of this article.

Authors' contributions

YJ, SL and YW analyzed clinical data, obtained medical images and advised on patient treatment. YZ performed the pathological diagnosis and contributed to the interpretation of pathological findings. ZC and BL designed the study and performed the surgery. ZC and BL confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

The present case report was prepared in accordance with the CARE guidelines.

Patient consent for publication

Written informed consent was obtained from the patient and their family for the publication of the present case report.

Competing interests

The authors declare that they have no competing interests.

References

1 

Ghanem KG, Ram S and Rice PA: The modern epidemic of syphilis. N Engl J Med. 382:845–854. 2020.PubMed/NCBI View Article : Google Scholar

2 

Peeling RW, Mabey D, Chen XS and Garcia PJ: Syphilis. Lancet. 402:336–346. 2023.PubMed/NCBI View Article : Google Scholar

3 

Ropper AH: Neurosyphilis. N Engl J Med. 381:1358–1363. 2019.PubMed/NCBI View Article : Google Scholar

4 

Drago F, Merlo G, Ciccarese G, Agnoletti AF, Cozzani E, Rebora A and Parodi A: Changes in neurosyphilis presentation: A survey on 286 patients. J Eur Acad Dermatol Venereol. 30:1886–1900. 2016.PubMed/NCBI View Article : Google Scholar

5 

Fargen KM, Alvernia JE, Lin CS and Melgar M: Cerebral syphilitic gummata: A case presentation and analysis of 156 reported cases. Neurosurgery. 64:568–575, discussioin 575-6. 2009.PubMed/NCBI View Article : Google Scholar

6 

Cushing H: Further concerning a parasympathetic center in the interbrain: VII. The effect of intraventricularly-injected histamine. Proc Natl Acad Sci USA. 18:500–510. 1932.PubMed/NCBI View Article : Google Scholar

7 

Grant FC: A study of the results of surgical treatment in 2,326 consecutive patients with brain tumor. J Neurosurg. 13:479–488. 1956.PubMed/NCBI View Article : Google Scholar

8 

Katsura S, Suzuki J and Wada T: A statistical study of brain tumors in the neurosurgical clinics in Japan. J Neurosurg. 16:570–580. 1959.PubMed/NCBI View Article : Google Scholar

9 

Barthel L, Hetze S, Teuber-Hanselmann S, Chapot V and Sure U: Syphilitic gummata in the central nervous system: A narrative review and case report about a noteworthy clinical manifestation. Microorganisms. 9(906)2021.PubMed/NCBI View Article : Google Scholar

10 

Kanayama S, Nagata S, Akiyama Y, Miyazato Y, Ishikane M, Inoue M, Ohmagari N and Hara T: Cerebral syphilitic gumma in the modern era: A report of an unusual case and brief review of recent published reports. Br J Neurosurg. 38:1283–1288. 2024.PubMed/NCBI View Article : Google Scholar

11 

Ramrakhiani N, Sukhani PK and Dubey R: Neurosyphilis-a forgotten disease: Case reports with ten years follow-up and review of literature. Neurol India. 68:889–893. 2020.PubMed/NCBI View Article : Google Scholar

12 

Baskar D, R Taallapalli AV, Kishore P, Arshad F, Kulanthaivelu K, Nashi S, Rajendran SP, Kulkarni GB and Alladi S: A rare case of neurosyphilis presenting as normal pressure hydrocephalus syndrome. Neurol India. 70:377–379. 2022.PubMed/NCBI View Article : Google Scholar

13 

Sasaki R, Tanaka N, Okazaki T and Yonezawa T: Multiple cerebral syphilitic gummas mimicking brain tumor in a non-HIV-infected patient: A case report. J Infect Chemother. 25:208–211. 2019.PubMed/NCBI View Article : Google Scholar

14 

Drago F, Ciccarese G and Rebora A: Treatment of late-stage syphilis. JAMA. 313(969)2015.PubMed/NCBI View Article : Google Scholar

15 

Zhang W, Xu D, Qin K, Song C, Miao R, Ma X, Kou C and Huang Y: Clinical, radiological, and pathological features of cerebral and spinal syphilitic gumma: A cross-sectional study. Int J Gen Med. 18:4501–4510. 2025.PubMed/NCBI View Article : Google Scholar

16 

Zayet S, Poloni S, Gendrin V, Chanal J, Dupin N and Klopfenstein T: Early neurosyphilis with serofast state. Emerg Microbes Infect. 13(2373305)2024.PubMed/NCBI View Article : Google Scholar

17 

Zhang L, Zhou Y, Chen J, Yan W, Kong Q, Chen P and Sang H: A case of a cerebral syphilitic gumma developed in a few months mimicking a brain tumor in a human immunodeficiency virus-negative patient. Br J Neurosurg. 31:481–483. 2017.PubMed/NCBI View Article : Google Scholar

18 

Forrestel AK, Kovarik CL and Katz KA: Sexually acquired syphilis: Laboratory diagnosis, management, and prevention. J Am Acad Dermatol. 82:17–28. 2020.PubMed/NCBI View Article : Google Scholar

19 

Shen S, Yang R, Wang L, Tang L and Liu B: Multiple intracranial and spinal cord syphilitic gummas in a human immunodeficiency virus-negative man with untreated syphilis: A case report. Medicine (Baltimore). 98(e16887)2019.PubMed/NCBI View Article : Google Scholar

20 

Mu LK, Cheng LF, Ye J, Zhao MY and Wang JL: Cerebral syphilitic gumma misdiagnosed as brain abscess: A case report. World J Clin Cases. 12:650–656. 2024.PubMed/NCBI View Article : Google Scholar

21 

Tsuboi M, Nishijima T, Teruya K, Kikuchi Y, Gatanaga H and Oka S: Cerebral syphilitic gumma within 5 months of syphilis in HIV-infected patient. Emerg Infect Dis. 22:1846–1848. 2016.PubMed/NCBI View Article : Google Scholar

22 

Waugh S, Ranasinghe A, Gomez A, Houston S, Lithgow KV, Eshghi A, Fleetwood J, Conway KME, Reynolds LA and Cameron CE: Syphilis and the host: Multi-omic analysis of host cellular responses to treponema pallidum provides novel insight into syphilis pathogenesis. Front Microbiol. 14(1254342)2023.PubMed/NCBI View Article : Google Scholar

23 

McVey M, Cameron W and MacPherson P: When infections collide-gummatous syphilis in an HIV-infected individual. Int J Infect Dis. (14 Suppl 3):e283–e286. 2010.PubMed/NCBI View Article : Google Scholar

24 

Ramchandani MS, Cannon CA and Marra CM: Syphilis: A modern resurgence. Infect Dis Clin North Am. 37:195–222. 2023.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ji Y, Liu S, Wang Y, Zhao Y, Cai Z and Li B: A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report. Exp Ther Med 31: 119, 2026.
APA
Ji, Y., Liu, S., Wang, Y., Zhao, Y., Cai, Z., & Li, B. (2026). A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report. Experimental and Therapeutic Medicine, 31, 119. https://doi.org/10.3892/etm.2026.13114
MLA
Ji, Y., Liu, S., Wang, Y., Zhao, Y., Cai, Z., Li, B."A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report". Experimental and Therapeutic Medicine 31.5 (2026): 119.
Chicago
Ji, Y., Liu, S., Wang, Y., Zhao, Y., Cai, Z., Li, B."A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report". Experimental and Therapeutic Medicine 31, no. 5 (2026): 119. https://doi.org/10.3892/etm.2026.13114
Copy and paste a formatted citation
x
Spandidos Publications style
Ji Y, Liu S, Wang Y, Zhao Y, Cai Z and Li B: A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report. Exp Ther Med 31: 119, 2026.
APA
Ji, Y., Liu, S., Wang, Y., Zhao, Y., Cai, Z., & Li, B. (2026). A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report. Experimental and Therapeutic Medicine, 31, 119. https://doi.org/10.3892/etm.2026.13114
MLA
Ji, Y., Liu, S., Wang, Y., Zhao, Y., Cai, Z., Li, B."A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report". Experimental and Therapeutic Medicine 31.5 (2026): 119.
Chicago
Ji, Y., Liu, S., Wang, Y., Zhao, Y., Cai, Z., Li, B."A rare case of early‑onset cerebral syphilitic gummata with severe neurological decline in early‑stage syphilis: A case report". Experimental and Therapeutic Medicine 31, no. 5 (2026): 119. https://doi.org/10.3892/etm.2026.13114
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team